Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Barrett

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
Blood Advances|October 1, 2020
Lingering effects of chemotherapy on mature T cells impair proliferationRajat K Das, Roddy S O'Connor, Stephan A Grupp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2012
The future is now: chimeric antigen receptors as new targeted therapies for childhood cancerDaniel W Lee, David M Barrett, Crystal Mackall, et al.
Molecular and Cellular Biology|July 1, 2004
A GATA factor mediates cell type-restricted induction of HLA-E gene transcription by gamma interferonDavid M Barrett, Karen S Gustafson, Jing Wang, et al.
Annual Review of Medicine|November 27, 2013
Chimeric antigen receptor therapy for cancerDavid M Barrett, Nathan Singh, David L Porter, et al.
Frontiers in Immunology|August 26, 2021
Distinct Bioenergetic Features of Human Invariant Natural Killer T Cells Enable Retained Functions in Nutrient-Deprived StatesPriya Khurana, Chakkapong Burudpakdee, Stephan A Grupp, et al.
Human Gene Therapy|July 26, 2013
Regimen-specific effects of RNA-modified chimeric antigen receptor T cells in mice with advanced leukemiaDavid M Barrett, Xiaojun Liu, Shuguang Jiang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 14, 2013
Immunologic recovery in children after alternative donor allogeneic transplantation for hematologic malignancies: comparison of recipients of partially T cell-depleted peripheral blood stem cells and umbilical cord bloodBenjamin R Oshrine, Yimei Li, David T Teachey, et al.
Cancer Immunology Research|October 18, 2022
Characterization of Leukemic Resistance to CD19-Targeted CAR T-cell Therapy through Deep Genomic SequencingGregory M Chen, Chia-Hui Chen, Jessica Perazzelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2020
Dissecting the Tumor-Immune Landscape in Chimeric Antigen Receptor T-cell Therapy: Key Challenges and Opportunities for a Systems Immunology ApproachGregory M Chen, Andrew Azzam, Yang-Yang Ding, et al.
Cytotherapy|January 21, 2014
Relation of clinical culture method to T-cell memory status and efficacy in xenograft models of adoptive immunotherapyDavid M Barrett, Nathan Singh, Xiaojun Liu, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Blood Advances|October 1, 2020
Lingering effects of chemotherapy on mature T cells impair proliferationRajat K Das, Roddy S O'Connor, Stephan A Grupp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2012
The future is now: chimeric antigen receptors as new targeted therapies for childhood cancerDaniel W Lee, David M Barrett, Crystal Mackall, et al.
Molecular and Cellular Biology|July 1, 2004
A GATA factor mediates cell type-restricted induction of HLA-E gene transcription by gamma interferonDavid M Barrett, Karen S Gustafson, Jing Wang, et al.
Annual Review of Medicine|November 27, 2013
Chimeric antigen receptor therapy for cancerDavid M Barrett, Nathan Singh, David L Porter, et al.
Frontiers in Immunology|August 26, 2021
Distinct Bioenergetic Features of Human Invariant Natural Killer T Cells Enable Retained Functions in Nutrient-Deprived StatesPriya Khurana, Chakkapong Burudpakdee, Stephan A Grupp, et al.
Human Gene Therapy|July 26, 2013
Regimen-specific effects of RNA-modified chimeric antigen receptor T cells in mice with advanced leukemiaDavid M Barrett, Xiaojun Liu, Shuguang Jiang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 14, 2013
Immunologic recovery in children after alternative donor allogeneic transplantation for hematologic malignancies: comparison of recipients of partially T cell-depleted peripheral blood stem cells and umbilical cord bloodBenjamin R Oshrine, Yimei Li, David T Teachey, et al.
Cancer Immunology Research|October 18, 2022
Characterization of Leukemic Resistance to CD19-Targeted CAR T-cell Therapy through Deep Genomic SequencingGregory M Chen, Chia-Hui Chen, Jessica Perazzelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2020
Dissecting the Tumor-Immune Landscape in Chimeric Antigen Receptor T-cell Therapy: Key Challenges and Opportunities for a Systems Immunology ApproachGregory M Chen, Andrew Azzam, Yang-Yang Ding, et al.
Cytotherapy|January 21, 2014
Relation of clinical culture method to T-cell memory status and efficacy in xenograft models of adoptive immunotherapyDavid M Barrett, Nathan Singh, Xiaojun Liu, et al.
Pageof 8